MedCity News November 20, 2024
Stephanie Baum

Personify Health Chief Medical Officer Jeff Jacques offers a window into companies’ strategies for including GLP-1 drugs in their health benefits.

At a time when self-insured employers are searching for ways to address escalating healthcare costs, the rise of GLP-1 drugs for weight loss poses some interesting questions for employers. Could investment in these pricey drugs as a health benefit stem the cost of chronic conditions in the long term? How do employers decide who should get access to these...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

Continue Reading

 
Topics: Biotechnology, Conferences / Podcast, Insurance, Pharma / Biotech, Self-insured, Trends
Related Articles:
From MSSP ACOs to Employer Value: Translating Value-Based Principles to Self-Insured Plans
Legal Issues in Value-Based Care Contracts for Self-Insured Employers
Restoring Affordability to Employer Health Plans
Carrum Health Expands SUD Treatment Program to Include Nearly All Substances
Healthcare Benefit Trends Report: Employers Shift to More Independent Navigation, Embrace GLP-1 Drugs with Restrictions

Share Article